Reference
·Primary source
Thailand pharmaceutical distribution and wholesale revenue (2020-2024)
~THB 270B (2024)
Thailand's pharmaceutical distribution and wholesale sector generated approximately THB 270 billion in revenue in 2024 per Pharmaceutical Research and Manufacturers Association (PReMA) and Ministry of Public Health estimates, up from THB 220 billion in 2020. The compound annual growth rate of roughly 5-6% reflects the underlying drug market expansion, ageing demographics, and continued shift toward branded chronic-disease therapeutics. The distribution layer captures gross margin of 8-12% on imported originator drugs and 12-18% on generics, with the residual flowing to hospitals, retail pharmacies, and the Government Pharmaceutical Organisation (GPO) state procurement channel.
Figure in context
Thailand's pharmaceutical distribution and wholesale sector generated approximately THB 270 billion in revenue in 2024 per Pharmaceutical Research and Manufacturers Association (PReMA) and Ministry of Public Health estimates, up from THB 220 billion in 2020. The compound annual growth rate of roughly 5-6% reflects the underlying drug market expansion, ageing demographics, and continued shift toward branded chronic-disease therapeutics. The distribution layer captures gross margin of 8-12% on imported originator drugs and 12-18% on generics, with the residual flowing to hospitals, retail pharmacies, and the Government Pharmaceutical Organisation (GPO) state procurement channel.
Interpretation notes
What this tells you
Thailand's pharmaceutical distribution and wholesale sector generated approximately THB 270 billion in revenue in 2024 per Pharmaceutical Research and Manufacturers Association (PReMA) and Ministry of Public Health estimates, up from THB 220 billion in 2020. The compound annual growth rate of roughly 5-6% reflects the underlying drug market expansion, ageing demographics, and continued shift toward branded chronic-disease therapeutics. The distribution layer captures gross margin of 8-12% on imported originator drugs and 12-18% on generics, with the residual flowing to hospitals, retail pharmacies, and the Government Pharmaceutical Organisation (GPO) state procurement channel.
What not to do with it
Values in THB billion. Revenue covers wholesale and distribution of human pharmaceuticals; excludes veterinary and OTC nutraceuticals.
Related figures
Adjacent numbers that add context without drowning the value.
Thailand pharmaceutical distributor market share (2024)
DKSH Group investor disclosures, Zuellig Pharma corporate filings, PReMA member surveys
Thailand pharmacy chain store count (2020-2024)
Boots Thailand corporate disclosures, Watsons CK Hutchison investor materials, Pharmacy Council of Thailand registry
DKSH Thailand healthcare segment revenue (2020-2024)
DKSH Group annual reports, DKSH Q4 trading updates, SIX Swiss Exchange disclosures
Thai FDA new drug registration approvals (2020-2024)
Thai Food and Drug Administration annual report, Ministry of Public Health, PReMA regulatory tracking
Government Pharmaceutical Organisation (GPO) state procurement
Government Pharmaceutical Organisation annual report, Ministry of Public Health, National Health Security Office
Thailand pharmaceutical cold-chain share of distribution
PReMA cold-chain working group, DKSH Thailand healthcare disclosure, Thai FDA Good Distribution Practice guidance
Report context
Atlas actors in this figure's reports
Profiles covered in the report that cite this number.